Holen Sie sich die Stockscreener-App
0.00
100.00%
-6.365
Handel nachbörslich:
6.40
6.40
+
Schlusskurs vom Vortag:
$6.365
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$15.16M
Einnahmen:
$74,000
Nettoeinkommen (Verlust:
$-13.43M
KGV:
0.00
EPS:
-9.4
Netto-Cashflow:
$-10.54M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$19.87
Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile
Firmenname
Cyclacel Pharmaceuticals Inc
Sektor
Branche
Telefon
908-517-7330
Adresse
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Vergleichen Sie CYCC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYCC
Cyclacel Pharmaceuticals Inc
|
0.00 | 15.16M | 74,000 | -13.43M | -10.54M | -9.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-04-27 | Fortgesetzt | ROTH Capital | Buy |
| 2018-09-07 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2015-10-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2010-02-04 | Eingeleitet | Roth Capital | Buy |
| 2009-10-28 | Eingeleitet | Merriman | Buy |
| 2008-08-12 | Eingeleitet | Piper Jaffray | Buy |
| 2008-03-12 | Bestätigt | Cantor Fitzgerald | Buy |
| 2008-03-12 | Bestätigt | Collins Stewart | Buy |
| 2008-03-12 | Bestätigt | Needham & Co | Buy |
| 2007-11-27 | Bestätigt | Cantor Fitzgerald | Buy |
| 2007-08-10 | Bestätigt | Cantor Fitzgerald | Buy |
| 2007-06-04 | Bestätigt | Needham & Co | Buy |
| 2007-04-23 | Eingeleitet | Lazard Capital | Buy |
| 2007-04-10 | Eingeleitet | Cantor Fitzgerald | Buy |
Alle ansehen
Cyclacel Pharmaceuticals Inc Aktie (CYCC) Neueste Nachrichten
Market Review: Can Cyclacel Pharmaceuticals Inc. stock hit analyst price targetsStock Surge & Verified Momentum Stock Ideas - moha.gov.vn
Cyclacel Pharmaceuticals Inc Stock Analysis and ForecastResistance Breakout Alerts & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Cyclacel Pharmaceuticals (BGMS) Stock Chart and Price History 2025 - MarketBeat
Cyclacel Pharmaceuticals (BGMS) Stock Trends and Sentiment 2025 - MarketBeat
Cyclacel Pharmaceuticals (BGMS) Competitors and Alternatives 2025 - MarketBeat
Should I hold or sell Cyclacel Pharmaceuticals Inc. stock in 20252025 Big Picture & Real-Time Volume Surge Alerts - newser.com
Cyclacel Pharmaceuticals (NASDAQ:BGMS) Rating Increased to Hold at Wall Street Zen - Defense World
Cyclacel Pharmaceuticals (BGMS) Stock Price, News & Analysis - MarketBeat
How Cyclacel Pharmaceuticals Inc. stock trades during market volatilityJuly 2025 Summary & Free Long-Term Investment Growth Plans - newser.com
Is Cyclacel Pharmaceuticals Inc. stock in correction or buying zoneJuly 2025 Institutional & Long-Term Investment Growth Plans - newser.com
Is Cyclacel Pharmaceuticals Inc. stock resilient to inflation2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Visual analytics tools that track Cyclacel Pharmaceuticals Inc. performance2025 Biggest Moves & Smart Money Movement Tracker - newser.com
Can Cyclacel Pharmaceuticals Inc. stock deliver surprise earnings beatEntry Point & Risk Managed Investment Signals - newser.com
Is Cyclacel Pharmaceuticals Inc. stock attractive for passive investorsWeekly Risk Summary & High Yield Equity Trading Tips - newser.com
Why Cyclacel Pharmaceuticals Inc. stock is popular among millennialsPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com
Will Cyclacel Pharmaceuticals Inc. stock reach all time highs in 2025 - newser.com
Order flow analysis tools used on Cyclacel Pharmaceuticals Inc.Portfolio Value Summary & Real-Time Stock Entry Alerts - newser.com
Published on: 2025-11-16 16:56:09 - newser.com
Evaluating Cyclacel Pharmaceuticals Inc. with trendline analysisJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
What to do if you’re stuck in Cyclacel Pharmaceuticals Inc.Weekly Risk Summary & Safe Capital Growth Stock Tips - newser.com
Can Cyclacel Pharmaceuticals Inc. stock resist sector downturnsGap Up & High Yield Stock Recommendations - newser.com
Can trapped investors hope for a rebound in Cyclacel Pharmaceuticals Inc.Market Risk Report & Daily Stock Momentum Reports - newser.com
Will Cyclacel Pharmaceuticals Inc. stock see insider buyingIndex Update & AI Enhanced Trading Alerts - newser.com
Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update - The Manila Times
Is Cyclacel Pharmaceuticals Inc. stock a good choice for value investorsQuarterly Portfolio Summary & Weekly High Potential Alerts - newser.com
Bio Green Med Solution’s Strategic Shift and Q3 Results - TipRanks
[10-Q] Bio Green Med Solution, Inc. Quarterly Earnings Report | BGMS SEC FilingForm 10-Q - Stock Titan
Finanzdaten der Cyclacel Pharmaceuticals Inc-Aktie (CYCC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):